Xiaoguang Margaret Liu

16PUBLICATIONS
20CO-AUTHORS
Gene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical molecular engineering of nucleic acids and proteinsTissue engineering
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jul 15, 2026
Humanized antibody-drug conjugates for Somatostatin receptor 2 (SSTR2)-positive tumor treatment.

|Apr 21, 2026
Advanced CD276-Targeting Dual-Payload Antibody-Drug Conjugates for Cancer Therapy.

|Oct 29, 2025
Correction: Si et al. Dual-Targeted Extracellular Vesicles to Facilitate Combined Therapies for Neuroendocrine Cancer Treatment. Pharmaceutics 2020, 12, 1079.

Yingnan Si, JiaShiung Guan, Yuanxin Xu

|Sep 17, 2024
mLumiOpto Is a Mitochondrial-Targeted Gene Therapy for Treating Cancer.

Kai Chen, Patrick Ernst, Anusua Sarkar

|Aug 26, 2024
A Dual-Payload Antibody-Drug Conjugate Targeting CD276/B7-H3 Elicits Cytotoxicity and Immune Activation in Triple-Negative Breast Cancer.

Zhuoxin Zora Zhou, Yingnan Si, Jiashuai Zhang

|Jan 23, 2024
Correction: Chen et al. Targeted Extracellular Vesicles Delivered Verrucarin A to Treat Glioblastoma. Biomedicines 2022, 10, 130.

Kai Chen, Yingnan Si, Jia-Shiung Guan

Pageof 3

Frequent Collaborators

6 joint publications

Lufang Zhou

3 joint publications

Yingnan Si

3 joint publications

Zhuoxin Zora Zhou

3 joint publications

Jiashuai Zhang